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After the publication of this work [1], we noticed an
error whereby the images of Figure 1 and Figure 2 are
interchanged and therefore do not correspond to their
legends. The image of Figure 1 belongs to Figure 2 and
vice versa. The corrected figures are given below.* Correspondence: jasmin.bartl@kjpdzh.ch
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Figure 1 Murine neural stem cell (mNSC) differentiation into immature neurons. A) mNSCs were treated with different concentration (0nM,
1nM, 10nM, 100nM) of methylphenidate (MPH). The percentage (% control) of developed neurons was determined 4 days after treatment with
MPH. The amount of immature neurons was analyzed by counting the neuron-specific class III beta-tubulin (Tuj 1) positive cells in comparison to
the total number of cells by using the Mann–Whitney (U-Rang) Test; -– = p <0.05; n = 28; seven independent experiments and four wells/slide of
each concentration were evaluated. B) An example of an immunocytochemistry staining of Tuj 1 in a control sample (no MPH treatment). The
white arrow points to a Tuj 1 positive cell (green) and the white arrow points to a cell nucleus staining with Hoechst (blue); 40x magnification.
© 2013 Bartl et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Figure 2 Murine neural stem cell (mNSC) proliferation. A) mNSCs were treated with different concentration (0nM, 1nM, 10nM, 100nM) of
methylphenidate (MPH). The percentage (% of control) of proliferated cells was determined 28 h after induction of neuronal proliferation and
MPH treatment. The amount of proliferating cells was analyzed by counting the Bromodeoxyurdine (BrdU) positive cells in comparison to the
total number of cells using the Mann–Whitney (U-Rang) Test; -– = p <0.05; n = 20; five independent experiments and four wells/slide of each
concentration were evaluated. B) An example of an immunocytochemistry staining of BrdU in a control sample (no MPH treatment). The white
arrow points to a BrdU positive cell (red) and the white arrow points to a BrdU negative cell (blue); 10x magnification.
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